Clinical trial
Phase III in Partial and Null Responders
NCT01485991 is registered in ClinicalTrials.gov with Janssen R&D Ireland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III in Partial and Null Responders
- Lead sponsor
- Janssen R&D Ireland
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- April 30, 2014
- Enrollment
- 771 (actual)
- Sites
- 137
Conditions
As the registry lists them; a condition with its own page is linked.